PL1922309T3 - Pochodne n-fenylo-2-pirymidynoaminy oraz sposób ich otrzymywania - Google Patents

Pochodne n-fenylo-2-pirymidynoaminy oraz sposób ich otrzymywania

Info

Publication number
PL1922309T3
PL1922309T3 PL05808814T PL05808814T PL1922309T3 PL 1922309 T3 PL1922309 T3 PL 1922309T3 PL 05808814 T PL05808814 T PL 05808814T PL 05808814 T PL05808814 T PL 05808814T PL 1922309 T3 PL1922309 T3 PL 1922309T3
Authority
PL
Poland
Prior art keywords
pyrimidine
phenyl
preparation
amine derivatives
amine
Prior art date
Application number
PL05808814T
Other languages
English (en)
Inventor
Dong-Yeon Kim
Dae-Jin Cho
Gong-Yeal Lee
Hong-Youb Kim
Seok-Hun Woo
Yong-Seok Kim
Sun-Ahe Lee
Byoung-Cheol Han
Original Assignee
Il Yang Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Yang Pharm Co Ltd filed Critical Il Yang Pharm Co Ltd
Publication of PL1922309T3 publication Critical patent/PL1922309T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
PL05808814T 2005-08-05 2005-09-07 Pochodne n-fenylo-2-pirymidynoaminy oraz sposób ich otrzymywania PL1922309T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020050071656A KR100674813B1 (ko) 2005-08-05 2005-08-05 N-페닐-2-피리미딘-아민 유도체 및 그의 제조방법
EP05808814.7A EP1922309B1 (en) 2005-08-05 2005-09-07 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
PCT/KR2005/002962 WO2007018325A1 (en) 2005-08-05 2005-09-07 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof

Publications (1)

Publication Number Publication Date
PL1922309T3 true PL1922309T3 (pl) 2014-11-28

Family

ID=37727490

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05808814T PL1922309T3 (pl) 2005-08-05 2005-09-07 Pochodne n-fenylo-2-pirymidynoaminy oraz sposób ich otrzymywania

Country Status (16)

Country Link
US (1) US7501424B2 (pl)
EP (1) EP1922309B1 (pl)
JP (1) JP5094721B2 (pl)
KR (1) KR100674813B1 (pl)
CN (1) CN101155786B (pl)
AU (1) AU2005335298C1 (pl)
CA (1) CA2617991C (pl)
DK (1) DK1922309T3 (pl)
EA (1) EA015103B1 (pl)
ES (1) ES2493627T3 (pl)
MX (1) MX2008001221A (pl)
NZ (1) NZ564908A (pl)
PL (1) PL1922309T3 (pl)
PT (1) PT1922309E (pl)
RS (1) RS53379B (pl)
WO (1) WO2007018325A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100654039B1 (ko) 2005-11-14 2006-12-05 에스케이 텔레콤주식회사 무선 인터넷에서 서비스 서버의 인증방법 및 이를 이용한결제방법
EP2684874B1 (en) 2006-10-23 2017-05-17 Cephalon, Inc. Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors
RU2009120882A (ru) * 2006-11-03 2010-12-10 Айрм Ллк (Bm) Соединения и композиции, как ингибиторы протеинкиназы
CA2686382C (en) * 2007-05-04 2013-09-17 Irm Llc Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors
ES2381318T3 (es) * 2007-05-04 2012-05-25 Irm Llc Derivados de pirimidina y composiciones útiles como inhibidores de cinasas C-KIT y PDGFR
EP2152079A4 (en) 2007-06-04 2011-03-09 Avila Therapeutics Inc HETEROCYCLIC COMPOUNDS AND USES THEREOF
KR101171488B1 (ko) 2007-08-22 2012-08-07 아이알엠 엘엘씨 키나제 억제제로서의 2-헤테로아릴아미노-피리미딘 유도체
EP2305667A3 (en) 2008-07-17 2011-05-11 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
KR20100021321A (ko) * 2008-08-14 2010-02-24 일양약품주식회사 Ν-페닐-2-피리미딘-아민 유도체의 제조방법
EP2262793B1 (en) 2008-11-05 2012-10-03 Teva Pharmaceutical Industries Ltd. Nilotinib hci crystalline forms
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
CA2798578C (en) 2010-05-21 2015-12-29 Chemilia Ab Novel pyrimidine derivatives
CA2830129C (en) 2011-03-24 2016-07-19 Chemilia Ab Novel pyrimidine derivatives
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
RU2486180C1 (ru) * 2011-11-02 2013-06-27 Общество с ограниченной ответственностью "ТехноХим" (ООО "ТехноХим") Способ получения 2-ариламино-4-гетарилпиримидинов
KR101956586B1 (ko) * 2012-03-27 2019-03-11 일양약품주식회사 약제학적 조성물 및 이의 제조방법
JP5910311B2 (ja) * 2012-05-23 2016-04-27 ニプロ株式会社 医薬錠剤およびその製造方法
CN104940748A (zh) * 2015-06-09 2015-09-30 林正兴 一种治疗胃癌的药物组合物
EP3609882B1 (en) 2017-03-17 2022-07-13 Cardio Therapeutics Pty Ltd Heterocyclic inhibitors of pcsk9
CN107056713A (zh) * 2017-05-18 2017-08-18 厦门大学 4‑((4‑取代芳基‑2‑嘧啶基)氨基)苯甲酰肼衍生物及其制备方法和应用
CN111039932B (zh) * 2019-12-13 2023-09-12 安徽峆一药业股份有限公司 一种拉多替尼的高收率合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
US6368651B1 (en) 1999-05-13 2002-04-09 The Nutrasweet Company Use of additives to modify the taste characteristics of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester
AU7322100A (en) 1999-10-04 2001-05-10 Ajinomoto Co., Inc. Sweetener compositions with high degree of sweetness having improved sweetness, corrigents and utilization thereof
GB0021726D0 (en) * 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0022438D0 (en) * 2000-09-13 2000-11-01 Novartis Ag Organic Compounds
DK1330452T3 (da) * 2000-09-20 2009-03-16 Ortho Mcneil Janssen Pharm Pyrazinderivater som modulatorer af tyrosinkinaser
US7129242B2 (en) * 2000-12-06 2006-10-31 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
WO2002096905A1 (en) * 2001-06-01 2002-12-05 Vertex Pharmaceuticals Incorporated Thiazole compounds useful as inhibitors of protein kinases
US6958340B2 (en) * 2001-08-01 2005-10-25 Merck & Co., Inc. Tyrosine kinase inhibitors
JP4552650B2 (ja) * 2002-06-28 2010-09-29 日本新薬株式会社 アミド誘導体及び医薬
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
ATE396731T1 (de) * 2003-03-25 2008-06-15 Vertex Pharma Thiazole zur verwendung als inhibitoren von protein-kinasen
US20040235834A1 (en) * 2003-03-25 2004-11-25 Farmer Luc J. Thiazoles useful as inhibitors of protein kinases
AU2003232650A1 (en) 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
CA2529090A1 (en) * 2003-06-13 2004-12-23 Novartis Ag 2-aminopyrimidine derivatives as raf kinase inhibitors
DK1702917T3 (da) * 2003-12-25 2017-11-13 Nippon Shinyaku Co Ltd Amidderivat og medicin
JPWO2005063720A1 (ja) * 2003-12-25 2007-07-19 日本新薬株式会社 アミド誘導体及び医薬
WO2005113550A1 (ja) * 2004-05-20 2005-12-01 Mitsubishi Pharma Corporation アミノピリミジン誘導体及びその医薬としての用途

Also Published As

Publication number Publication date
RS20080002A (en) 2009-07-15
WO2007018325A1 (en) 2007-02-15
AU2005335298C1 (en) 2010-11-25
US7501424B2 (en) 2009-03-10
ES2493627T3 (es) 2014-09-12
AU2005335298B2 (en) 2010-05-27
US20080096899A1 (en) 2008-04-24
EP1922309A1 (en) 2008-05-21
DK1922309T3 (da) 2014-08-25
JP5094721B2 (ja) 2012-12-12
EA015103B1 (ru) 2011-06-30
KR100674813B1 (ko) 2007-01-29
EP1922309B1 (en) 2014-05-21
CA2617991A1 (en) 2007-02-15
RS53379B (en) 2014-10-31
MX2008001221A (es) 2009-02-24
CA2617991C (en) 2011-08-09
NZ564908A (en) 2011-02-25
EP1922309A4 (en) 2009-10-14
CN101155786B (zh) 2012-08-29
CN101155786A (zh) 2008-04-02
AU2005335298A1 (en) 2007-02-15
JP2009503060A (ja) 2009-01-29
EA200800516A1 (ru) 2008-08-29
PT1922309E (pt) 2014-09-02

Similar Documents

Publication Publication Date Title
EP1922309A4 (en) N-PHENYL-2-PYRIMDINAMINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
IL190135A0 (en) Process for the preparation of pyrimidinedione derivatives
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
EP1895853A4 (en) YOGHURT BEAUTY PRODUCTS AND METHOD OF PREPARING THEM
EP1951682A4 (en) NEW 2-AMINOPYRIMIDONE OR 2-AMINOPYRIDINONE DERIVATIVES AND THEIR USE
HUP0500920A2 (en) Oxadiazole derivatives, process for their preparation and their use
EP1893625A4 (en) PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES
EP1962635A4 (en) LOAD REDUCTION FOR SHOULDER AND USE THEREOF
IL184834A0 (en) Compositions and methods for the manufacture thereof
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
AU2003232650A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
EP1961753A4 (en) DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE
EP1834624A4 (en) MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR
HK1102395A1 (en) Indene derivatives and process for the preparation thereof
EP1874722A4 (en) HYDROXAMIC ACID DERIVATIVES AND PROCESSES FOR PREPARING THE SAME
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
EP1756036A4 (en) INDENED DERIVATIVES AND PROCESS FOR THEIR PREPARATION
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
IL189698A0 (en) Thiomorpholine derivatives and processes for the preparation thereof
IL194737A0 (en) 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
IL186059A0 (en) Carbapenem derivatives and processes for the preparation thereof